Delos Pharmaceuticals' Unattributed Round

Delos Pharmaceuticals raised a round of funding on June 28, 2017.

Delos Pharmaceuticals is focused on the discovery and development of novel polyketide-based therapies to treat chronic disease by targeting specific pathways implicated in several aging-related diseas…

Articles about Delos Pharmaceuticals' Unattributed Round: